Achillion Pharmaceuticals, Inc.

Basic Information

Achillion Pharmaceuticals, Inc.
300 George St, Ste 801
New Haven, CT, 06511 0665

Point of Contact Information

Field Value
Business Official:
Firm CFO (or equivalent):
POC Contracting Officer (or equivalent)

Additional Details

Field Value
SBC Control ID:
DUNS: n/a
CAGE: n/a
SIC Codes: n/a
NAICS Codes: n/a

Company Profile


  1. Novel Antibacterial Agents That Target DNA Replication in Mycobacterium tuberculo

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Mycobacterium tuberculosis (MTB) is probably the most ubiquitous microbial pathogen in the world today infecting one-third of the total population and causing mill ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Capsid assembly inhibitors for the treatment of AIDS

    Amount: $597,665.00

    DESCRIPTION (provided by applicant): Current HIV-1 therapy suffers from inadequate viral load suppression due to poor compliance, resistance, and interactions with other drugs and can lead to spread o ...

    SBIR Phase I 2005 Department of Health and Human Services

Agency Micro-sites

SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government